Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (192)

2024

  1. Impact of the ERS/ATS 2022 Guidelines for Interpretation of Lung Function Test Results When Assessing the Response to Biologics in Asthma

    Journal of Investigational Allergology and Clinical Immunology

  2. Regional, sex, and age inequities in asthma hospital admissions in Spain and Portugal

    Clinical and Translational Allergy

2023

  1. A Prospective Study of Costs Associated With the Evaluation of Allergic Reactions to Radiological Contrast Media

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 102-108

  2. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  3. An Exceptional Case of Recall Phenomenon to Hypersensitivity to Amoxicillin

    Dermatitis, Vol. 34, Núm. 5, pp. 452-453

  4. Basic assessment of chronic cough in primary care and referral pathways of patients to different specialists

    Therapeutic Advances in Respiratory Disease, Vol. 17

  5. Biological treatments for asthma

    The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 265-283

  6. Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study

    ERJ Open Research, Vol. 9, Núm. 5

  7. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study

    Lung, Vol. 201, Núm. 3, pp. 275-286

  8. Contact Palpebral Dermatitis and Conjunctivitis Due to Delayed Hypersensitivity to Timolol

    Dermatitis

  9. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  10. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Biomedicines, Vol. 11, Núm. 7

  11. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

  12. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  13. Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

    International Journal of Immunopathology and Pharmacology, Vol. 37

  14. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  15. The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 439-445

  16. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Changes in Sensitization Patterns in the Last 25 Years in 619 Patients with Confirmed Diagnoses of Immediate Hypersensitivity Reactions to Beta-Lactams

    Biomedicines, Vol. 10, Núm. 7

  2. DRESS Syndrome Induced by a Gadolinium-Based Contrast Agent in a 13-Year-Old Boy

    Journal of investigational allergology & clinical immunology, Vol. 32, Núm. 3, pp. 238-240